Tagrisso plus chemotherapy achieves nearly four-year median overall survival in EGFR-mutated advanced lung cancer, setting new global standard in phase III trial
This approval follows the CDE’s clearance in July of this year for Phase 2/3 clinical studies of CB03-154 in amyotrophic lateral sclerosis
Shantived Hospital generated revenue of around Rs 50 crore in FY2025
Alembic receives EIR from USFDA for facility at Panelav
Rhonda Pacheco to succeed Julie Kim, who was appointed to be Takeda’s next CEO
Biocon Foundation is also expanding its reach with this first initiative in Channapatna region
Subscribe To Our Newsletter & Stay Updated